The CC chemokine RANTES in breast carcinoma progression: Regulation of expression and potential mechanisms of promalignant activity

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1093-1102

  Azenshtein, Elina ^a   Luboshits, Galia ^a   Shina, Sima ^a   Neumark, Eran ^a   Shahbazian, David ^a   Weil, Miguel ^a   Keydar, Iafa ^a   Ben Baruch, Adit ^a   Wigler, Nely ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CELL INFILTRATION; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS; MONOCYTE; PARACRINE SIGNALING; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHICK EMBRYO; CYTOKINES; DISEASE PROGRESSION; HUMANS; MATRIX METALLOPROTEINASE 9; RANTES;

EID: 0036174325     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Immunological enhancement of breast cancer
2. Angiogenesis and inflammation in invasive carcinoma of the breast
3. Macrophage-tumor cell associations in breast cancer
4. Macrophage-tumor cell associations: A factor in metastasis of breast cancer
5. Clinicopathologic analysis of macrophage infiltrates in breast carcinoma
6. Cytokine regulation of angiogenesis in breast cancer: The role of tumor-associated macrophages
7. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
8. Macrophages" and their putative significance in human breast cancer
9. Tumor-associated leukocytes: Friends or foes in breast carcinoma
10. An immunohistological study of leukocyte localization in benign and malignant breast tissue
11. + monocytic cells in the tumor stroma
12. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes
13. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines
14. The origin and function of tumor-associated macrophages
15. Tumor angiogenesis, macrophages, and cytokines
16. Chemokine receptors and their role in inflammation and infectious diseases
17. Chemokines and their role in tumor growth and metastasis
18. Significance of macrophage chemoattractant protein-I in macrophage recruitment, angiogenesis, and survival in human breast cancer
19. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
20. Expression of monocyte chemotactic protein-I in human invasive ductal breast cancer
21. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression
22. Physiological secretion of chemokines in human breast milk
23. Chemoattractant factors in breast milk from allergic and nonallergic mothers
24. RANTES chemokine expression in diseased and normal human tissues
25. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines
26. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice
27. Elevated expression of the CC chemokine regulated on activation. Normal T cell expressed and secreted (RANTES) in advanced breast carcinoma
28. Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation
29. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer
30. Establishment and characterization of a cell line of human breast carcinoma origin
31. MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells
32. Interleukin-8 receptor β: The role of the carboxyl terminus in signal transduction
33. Tumor necrosis factor-α and interferon-γ synergistically activate the RANTES promoter through nuclear factor κB and interferon regulatory factor I (IRF-1) transcription factors
34. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines
35. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids
36. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13
37. Migration responses of human monocytic cell lines to α- and β-chemokines
38. Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer
39. Roles of the matrix metalloproteinases in mammary gland development and cancer
40. Matrix metalloproteinases in the pathogenesis of breast cancer
41. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer
42. Matrix metalloproteinases and metastasis
43. The matrix metalloproteinase family
44. Gelatinase B functions as regulator and effector in leukocyte biology
45. Molecular mechanisms of tumor angiogenesis and tumor progression
46. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis
47. CXC chemokines in angiogenesis
48. Chemokines induce migrational responses in human breast carcinoma cell lines
49. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumor cells display positive and negative chemotaxis and differential in vivo growth potentials
50. TNF is here to stay!
51. Association of tumour necrosis factor α and its receptors with thymidine phosphorylase expression in invasive breast carcinoma
52. Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue